carvedilol has been researched along with thromboxane b2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Betterridge, DJ; Gasser, JA | 1 |
| Fabryova, V; Jancinova, V; Majekova, M; Nosal, R; Petrikova, M | 1 |
2 other study(ies) available for carvedilol and thromboxane b2
| Article | Year |
|---|---|
Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers.
Topics: Adrenergic beta-Antagonists; Blood Platelets; Carbazoles; Carvedilol; Coronary Disease; Cyclic AMP; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Propanolamines; Propranolol; Thromboxane B2; Vasodilator Agents; Verapamil | 1991 |
Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets.
Topics: Adrenergic beta-Antagonists; Atenolol; Carbazoles; Carvedilol; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Propanolamines; Propranolol; Thromboxane B2 | 2005 |